TENSION Study

This project receives fundung from the @EU_H2020 Research and Innovation Programme. Any related tweets reflect only the views of the project owner.

[TENSION Study @TENSIONstudy]

#TENSIONstudy: Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial

[TENSION Study @TENSIONstudy]

Great presentation of #maeritjensen of the design of the soon-to-begin #EAST-STROKE trial at the #WSC2024 in Abu Dhabi!

[Clinical Stroke and Imaging Research @CSI_Lab]

Wir suchen Verstärkung! 🧠

Du möchtest in der neurologischen Forschung etwas bewegen? Unser Schlaganfallzentrum sucht engagierte Studienärzt:innen!

Sei Teil eines Teams, das an spannenden Studien zur Schlaganfallbehandlung arbeitet und neue therapeutische Ansätze entwickelt

[Clinical Stroke and Imaging Research @CSI_Lab]

💡 Was Dich erwartet:

Spannende Forschungsprojekte
Interdisziplinäre Zusammenarbeit
Internationale Konferenzen & Fortbildungen

📅 Bewirb dich bis 18.11.2024! 👉 Jetzt mehr erfahren und bewerben: https://t.co/l9nN6rBXcZ

#Job #Neurologie #Forschung #Hamburg #UKE

[HamburgNeuro @HamburgNeuro]

The #UKEHamburg Department of Neurology is part of it. Looking forward to collaborate in this exciting project!

[Clinical Stroke and Imaging Research @CSI_Lab]

Endovascular thrombectomy for acute ischemic stroke with large infarct is cost-effective! Check the recent cost.-effectivity analysis based on @TENSIONstudy data.
https://t.co/yobLJq6Igy

[TENSION Study @TENSIONstudy]

New #TENSIONstudy publication shows that #thrombectomy is cost-effective for acute ischemic #stroke with established large infarct! https://t.co/21ssqg67ux

[Jens Fiehler @Fie0815]

TENSION large core stroke RCT 12M results: EVT advantage sustained. Quality of life much better after EVT (EQ-5D index score 0.7 vs. 0.4, p = 0.0024). Open access https://t.co/P3R7Zk9Adh @TheLancetNeuro

[TENSION Study @TENSIONstudy]

New data from @TENSIONstudy: benefits of EVT are sustained at 12 months - just published in the @TheLancetNeuro! 🆕

https://t.co/Gv4hdlHIof

[NeuroNews @NN_publishing]

The latest @TENSIONstudy data, presented by Götz Thomalla at #ESOC2024, point to the long-term efficacy of mechanical #Thrombectomy in ischaemic #Stroke patients with large infarcts—even when using a "simple and pragmatic" diagnostic algorithm
@ESOstroke
https://t.co/x6RmiBtb6H

[European Stroke Org @ESOstroke]

#TENSION study: RCT long-term outcome at 12 months: Benefit of EVT vs BMT on the mRS scale (OR 2.4) with higher EQ-5D index (p<.001) ⬆️ Also improvement for at least 1 point on mRS 3m to mRS 12m ✅️And all that with plain CT! @Fie0815 @Europal_EN @HorizonEU @StrokeEurope @ESMINT

[NeuroNews @NN_publishing]

More 12-month highlights:
- Thrombectomy associated with 17% absolute increase in ability to walk unaided
- Also associated with 30% relative reduction in mortality
- Long-term benefits similar to those in SELECT2, despite use of 'pragmatic' imaging approach
#ESOC2024 @ESOstroke

[NeuroNews @NN_publishing]

Götz Thomalla presents #ESOC2024 audiences with an update on the @TENSIONstudy: 12-month data suggest improved functional outcomes/QoL and lower mortality with #Thrombectomy versus medical therapy in large-core LVO #Stroke patients
@ESOstroke

[Clinical Stroke and Imaging Research @CSI_Lab]

We are excited to present the 12-month outcomes of our TENSION study at ESOC2024.
See us now at the poster session and delve into the relationship between heart and brain.

#tensionstudy #postersession #esoc2024

[European Stroke Org @ESOstroke]

@TENSIONstudy RCT long-term outcome at 12 months: Benefit of EVT vs BMT on the mRS scale (OR 2.4) with higher EQ-5D index (p<.001) ⬆️ Also improvement for at least 1 point on mRS 3m to mRS 12m ✅️ And all that with plain CT!
@Fie0815 @Europal_EN @HorizonEU @StrokeEurope @ESMINT

[TENSION Study @TENSIONstudy]

For our German speaking friends: The #TENSIONstudy results explained by Prof. Götz Thomalla (#UKEHamburg) on @tagesschau
https://t.co/TDlcrofymU

[TENSION Study @TENSIONstudy]

Congratulations for these results!!!

[Tudor G. Jovin, MD @TudorGJovin]

Humbled to have co-led this trial showing benefit of MT in early presenting pts with unlimitedly large infarcts.
Large core regardless of size = poor prognosis, but not treatment effect modifier.
IMAGING CANNOT IDENTIFY PTS WHO DON'T BENEFIT FROM MT !!

https://t.co/IBFBTYDRO8

[TENSION Study @TENSIONstudy]

Looking forward to the #ESOC2024 in Basel! The latest #TENSIONstudy data will be presented there!

[European Stroke Org @ESOstroke]

Exciting news: More Large Clinical Trials to be presented at #ESOC2024:
- ANNEXA-I
- TACTICS
- REMOTE-CAT
- RICH-2
- RECLAIM II
- CLEVER
- ACTISAVE
- INTERACT
- ANNEXA-I
- EMBOLISE
- SELECT2
- TENSION
- MR CLEAN No-IV
- TWIN2WIN

👉 https://t.co/xzZEzytmob

#stroke #stroketwitter

[Stroke Europe @StrokeEurope]

80% of strokes are preventable - effective prevention eases health system burden

In partnership with @ESOstroke we call on @Europarl_EN MEP candidates to reduce #stroke in Europe

Full manifeso👉🏼https://t.co/9bniqTYmWu

#EUelections #EUhealth #StrokeActionPlan #StrokePrevention

[Stroke Europe @StrokeEurope]

Dr Märit Jensen & Maximilian Schell were involved in the pan-European team that delivered @HorizonEU's @TENSIONstudy which showed that #thrombectomy is safe to use in more #stroke patients. Click to hear them explain more https://t.co/2cQImvlBtc #BrainAwarenessWeek

[Northern Ireland Chest Heart & Stroke @nichstweet]

For #BrainAwarenessWeek we're helping raise awareness of the importance of stroke research @StrokeEurope

The @HorizonEU @TENSIONstudy is showing that #thrombectomy is safe to use in a larger number of stroke patients. Prof Dr Simonsen explains what it means for #strokecare.